@conference{b89d291d162e491a9ac69f2821b7e05b,
title = "Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors. \#CT275: AACR ProcVol 83; (8\_Supplement): CT275. AACR meeting Orlando, FL, 2023.",
author = "B Carneiro and Rachel Sanborn and Hoon, \{Dave S.B.\} and \{See all authors in notes\}",
note = "294. Carneiro B, Garmezy B, Hamm JT, Sanborn RE, Wise-Draper T, El-Khoueiry A, Wilky B, Hoon DSB, Buffa A, Michelet X, Purbhoo M, Exley MA, Einstein D",
year = "2023",
language = "American English",
}